THR-β agonist 4

• UNSPSC Description:

  THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/thr-β-agonist-4.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1NC(N(C2=CC(Cl)=C(C(Cl)=C2)OC3=NC=C(C(S(=O)(NC)=O)=C3)O)N=C1C(F)F)=O

• Molecular Weight:

  510.26

• References & Citations:

  [1]Jingye Zhou, et al. Substituted triazinones as thyroid hormone receptor agonists. Patent WO2021143706A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2673409-25-9